Teva Pharmaceutical Indus... (TEVA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 16.66 |
Market Cap | 18.67B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -1.45 |
PE Ratio (ttm) | -11.36 |
Forward PE | n/a |
Analyst | Buy |
Ask | 16.85 |
Volume | 13,772,313 |
Avg. Volume (20D) | 11,763,684 |
Open | 17.15 |
Previous Close | 16.25 |
Day's Range | 16.34 - 17.15 |
52-Week Range | 12.51 - 22.80 |
Beta | undefined |
About TEVA
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and cr...
Analyst Forecast
According to 6 analyst ratings, the average rating for TEVA stock is "Buy." The 12-month stock price forecast is $24.5, which is an increase of 48.80% from the latest price.
Next Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription